The Competition and Markets Authority (CMA) has announced it is investigating whether HC-One’s acquisition of 122 Bupa care home represents an anti-competitive merger.
A public consultation was launched by the watchdog yesterday as it invited any comments on competition or public interests arising from the deal, which was confirmed in August (see BREAKING NEWS: HC-One agrees to buy 122 care homes).
“The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or service,” the watchdog said.
A spokesperson for HC-One commented: “Our mission is to be the first-choice care provider in each of the communities we serve, providing high-quality kind care to residents, and exceptional career development opportunities for colleagues.
“We are working closely with the CMA and are confident their review will find this acquisition does not give rise to any competition concerns.”
A spokesperson for Bupa UK added:”CMA clearance is a normal step in any transaction of this size and nature.”
The CMA is currently probing potential unfair practices within the care home sector and opened a consumer protection case into whether care homes were breaching consuming law in June (see BREAKING NEWS: CMA investigates whether care homes are breaking the law).